Conmed (NYSE: CNMD) reported Q2 EPS of $1.15, $0.03 better than the analyst estimate of $1.12. Revenue for the quarter came in at $342.34 million versus the consensus estimate of $338.4 million.

GUIDANCE:

Conmed sees FY2025 revenue of $1.36-1.39 billion, versus the consensus of $1.36 billion.

For earnings history and earnings-related data on Conmed (CNMD) click here.